Phenazopyridine hcl tab and Vytorin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenazopyridine hcl tab (phenazopyridine hydrochloride) and Vytorin (ezetimibe; simvastatin). Common drug interactions include cerebrovascular accident among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Phenazopyridine hcl tab and Vytorin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Phenazopyridine hcl tab?

Phenazopyridine hcl tab has active ingredients of phenazopyridine hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 1,123 Phenazopyridine hcl tab users. Check the latest studies of Phenazopyridine hcl tab.

What is Vytorin?

Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 20,084 Vytorin users. Check the latest studies of Vytorin.



On Jul, 10, 2026

28 people who take Phenazopyridine hcl tab and Vytorin together, and have interactions are studied.

Phenazopyridine hcl tab and Vytorin drug interactions.

What are the common drug interactions of Phenazopyridine Hcl Tab and Vytorin, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Intervertebral disc protrusion (spinal disc protrusion)
  3. Anxiety
  4. Back pain
  5. Depression
  6. Osteoporosis (bones weak and more likely to break)
  7. Pain
  8. Vomiting
  9. Dry mouth
  10. Impaired healing

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone erosion
  4. Dental caries
  5. Fall
  6. Groin pain
  7. Haematuria (presence of blood in urine)
  8. Nausea (feeling of having an urge to vomit)
  9. Neck pain
  10. Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Phenazopyridine Hcl Tab and Vytorin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Weight decreased
  2. White blood cell count decreased
  3. Diarrhoea
  4. Hypokalaemia (low potassium)
  5. Hypotension (abnormally low blood pressure)
  6. Joint dislocation (a joint position is changed from normal position)
  7. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  8. Pancreatitis relapsing
  9. Spondylolisthesis (displacement of a vertebra or the vertebral column in relation to the vertebrae below)
  10. Stress

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Cough
  3. Chorea (abnormal involuntary movement disorder)
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Death
  7. Disturbance in attention
  8. Dizziness
  9. Dry mouth
  10. Dyskinesia (abnormality or impairment of voluntary movement)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 32.14%
  2. Metastases To Bone (cancer spreads to bone): 9 people, 32.14%
  3. Pain: 3 people, 10.71%
  4. Neoplasm Malignant (cancer tumour): 3 people, 10.71%
  5. Indigestion: 3 people, 10.71%
  6. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 10.71%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  8. Diabetes: 3 people, 10.71%
  9. Depression: 3 people, 10.71%
  10. High Blood Pressure: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Phenazopyridine hcl tab and Vytorin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenazopyridine hcl tab and Vytorin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenazopyridine hcl tab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vytorin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenazopyridine hcl tab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vytorin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on phenazopyridine hydrochloride and ezetimibe; simvastatin (the active ingredients of Phenazopyridine hcl tab and Vytorin, respectively), and Phenazopyridine hcl tab and Vytorin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: